To B or not to B maintained?
In this issue of Blood , Bhoj et al explore the longevity of plasma cells (PCs) and humoral immunity in the absence of B cells. This is done by studying subjects experiencing B-cell aplasia after CD19-directed chimeric antigen receptor (CAR) therapy. 1
Gespeichert in:
| Veröffentlicht in: | Blood 2016-07, Vol.128 (3), p.317-318 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | In this issue of
Blood
,
Bhoj et al
explore the longevity of plasma cells (PCs) and humoral immunity in the absence of B cells. This is done by studying subjects experiencing B-cell aplasia after CD19-directed chimeric antigen receptor (CAR) therapy.
1 |
|---|---|
| ISSN: | 0006-4971 1528-0020 |
| DOI: | 10.1182/blood-2016-06-717538 |